Satilmis SRL
Satilmis reported total assets of 304,962 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Sep 2026).
The score of Satilmis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +565 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Satilmis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Sep 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
Satilmis's financial analysis
- Solvency43.0%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Satilmis
Satilmis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0778.684.821
- VAT number
- BE0778684821
- Peppol
- Registered · 0208:0778684821 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Dec 2021
- Registered office
- 1060 Saint-Gilles
- Latest accounts
- 2025 · filed on 15 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Satilmis (SRL) has been based in Saint-Gilles since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 21,038 € and equity of 130,986 €; its revenue is not published. Its solvency stands at 43.0%, above the median of its sector (37.6%).
Companies similar to Satilmis
Companies in the same business, of comparable size and area, outside its group.
- Nomota Activities of holding companies Berlaar · balance sheet 381,263 €
- Holding Pirotte Laura Activities of holding companies Houyet · balance sheet 464,856 €
- Jiwan Activities of holding companies Antwerp · balance sheet 198,041 €
- Pharmacie Dargent Retail sale of pharmaceutical products Anderlecht · balance sheet 278,471 €
- Camba-Pharma Retail sale of pharmaceutical products Ghent · balance sheet 437,825 €
- Apotheek DE Zuidflank Retail sale of pharmaceutical products Assenede · balance sheet 722,912 €
- Mancha Retail sale of pharmaceutical products Edegem · balance sheet 264,945 €
- B&B Pharma Retail sale of pharmaceutical products Beersel · balance sheet 811,436 €
Frequently asked questions about Satilmis
What is the revenue of Satilmis?
Satilmis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Satilmis?
In Belgium, the VAT number is the company number prefixed with BE: BE0778684821 for Satilmis, if the company is VAT-registered. Its company number (CBE) is 0778.684.821.
Where is the registered office of Satilmis?
According to the CBE register, the registered office of Satilmis is in 1060 Saint-Gilles.
What is the equity of Satilmis?
At the close of the 2025 financial year, the equity of Satilmis amounts to 130,986 €, a solvency of 43.0% of total assets.
Who manages Satilmis?
The register lists 2 active mandates at Satilmis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Satilmis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →